Efficacy of chronic pre-emptive rituximab treatment in ANCA-associated vasculitis
dc.contributor.author | Besada, Emilio | |
dc.contributor.author | Nossent, Johannes C | |
dc.date.accessioned | 2013-12-16T09:24:23Z | |
dc.date.available | 2013-12-16T09:24:23Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Scandinavian Journal of Rheumatology 41(2012) s. 41-42 | en |
dc.identifier.cristinID | FRIDAID 1023509 | |
dc.identifier.issn | 0300-9742 | |
dc.identifier.uri | https://hdl.handle.net/10037/5635 | |
dc.identifier.urn | URN:NBN:no-uit_munin_5340 | |
dc.language.iso | eng | en |
dc.publisher | Informa Healthcare | en |
dc.rights.accessRights | openAccess | |
dc.subject | VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Rheumatology: 759 | en |
dc.subject | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Reumatologi: 759 | en |
dc.title | Efficacy of chronic pre-emptive rituximab treatment in ANCA-associated vasculitis | en |
dc.type | Journal article | en |
dc.type | Tidsskriftartikkel | en |
dc.type | Peer reviewed | en |